Back to search
Peripheral Blood Stem Cell Transplantation
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Peripheral Blood Stem Cell Transplantation trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Peripheral Blood Stem Cell Transplantation trials you may qualify forThe purpose of this study is to find out if an investigational treatment will allow kidney transplant recipients to better accept their new kidney and stop immu…
Background: \- GATA2 deficiency is a disease caused by mutations in the GATA2 gene. It can cause different types of leukemia and other diseases. Researchers wa…
Graft-versus-host disease (GVHD) is a major complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT), significantly affecting survival…
This is a research protocol that will examine Hematopoietic Stem Cell Transplantation (HSCT) using a reduced conditioning regimen (RIC) with total body Irradiat…
A multi-centre phase II trial of GvHD prophylaxis following unrelated donor stem cell transplantation comparing Thymoglobulin vs. Calcineurin inhibitor or Sirol…
The aim of this study to evaluate the safety and efficacy of a nonmyeloablative conditioning regimen for allogeneic hematopoietic stem cell transplantation (HSC…
Background: Some blood cancers can be caused by germline variants (changes) in a person s RUNX1 gene. Germline variants are genetic inherited changes a person…
Chronic granulomatous disease (CGD) affects white blood cell function. Currently, the only curative treatment is bone marrow transplant to replace the abnormal…